Deshpande R V, Goust J M, Hogan E L, Banik N L
Department of Neurology, Medical University of South Carolina, Charleston 29425, USA.
J Neurosci Res. 1995 Oct 1;42(2):259-65. doi: 10.1002/jnr.490420214.
Calpain secreted by lymphoid (MOLT-3, M.R.) or monocytic (U-937, THP-1) cell lines activated with PMA and A23187 degraded myelin antigens. The degradative effect of enzymes released in the extracellular medium was tested on purified myelin basic protein and rat central nervous system myelin in vitro. The extent of protein degradation was determined by SDS-PAGE and densitometric analysis. Various proteinase inhibitors were used to determine to what extent protein degradation was mediated by calpain and/or other enzymes. Lysosomal and serine proteinase inhibitors inhibited 20-40% of the myelin-degradative activity found in the incubation media of cell lines, whereas the calcium chelator (EGTA), the calpain-specific inhibitor (calpastatin), and a monoclonal antibody to m calpain blocked myelin degradation by 60-80%. Since breakdown products of MBP generated by calpain may include fragments with antigenic epitopes, this enzyme may play an important role in the initiation of immune-mediated demyelination.
经佛波酯(PMA)和钙离子载体A23187激活的淋巴细胞系(MOLT-3、M.R.)或单核细胞系(U-937、THP-1)分泌的钙蛋白酶可降解髓鞘抗原。在体外对纯化的髓鞘碱性蛋白和大鼠中枢神经系统髓鞘测试了细胞外培养基中释放的酶的降解作用。通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)和光密度分析确定蛋白质降解程度。使用各种蛋白酶抑制剂来确定蛋白质降解在多大程度上由钙蛋白酶和/或其他酶介导。溶酶体和丝氨酸蛋白酶抑制剂抑制了细胞系孵育培养基中发现的20%-40%的髓鞘降解活性,而钙螯合剂(乙二醇双四乙酸,EGTA)、钙蛋白酶特异性抑制剂(钙蛋白酶抑制蛋白)和抗μ-钙蛋白酶单克隆抗体可阻断60%-80%的髓鞘降解。由于钙蛋白酶产生的髓鞘碱性蛋白(MBP)分解产物可能包括具有抗原表位的片段,该酶可能在免疫介导的脱髓鞘起始过程中起重要作用。